Delivery Order SPE2DE24DA017-SPE2D625F1GMK

Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies, received a $3,300 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, which carries an ultimate completion date of September 3, 2025, represents a task order issued against Arthrex's substantial indefinite delivery contract with the Defense Logistics Agency valued at approximately $471 million and running through September 1, 2029. This delivery order will be performed in Naples, Florida, where the company is headquartered. No set-aside designation was applied to this award, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace.

The Arthrex ACP Double Syringe System is part of the company's comprehensive portfolio of orthopedic surgical products and biologics that support the Department of Defense and the Veterans Health Administration. Arthrex has consistently demonstrated its capability to deliver specialized medical devices and surgical instruments to government healthcare systems, with prior delivery orders totaling over $550,000 under the parent indefinite delivery contract. The fixed-price structure with economic price adjustment provisions protects government interests while enabling efficient acquisition of this orthopedic surgical technology for military and veteran healthcare needs.